Skip to main content

Outcomes of Critically-Ill COVID Patients in NYC

Lancet has reported COVID outcomes from NewYork-Presbyterian hospitals in NYC during March 2020 showing high rates of hospitalization, ICU admission, mechanical ventilation and death. 

A prospective observational cohort study 2 2 NYC hospitals from March 2 to April 1, 2020, looking at laboratory-confirmed COVID-19 and were critically ill with acute hypoxaemic respiratory failure, and collected clinical, biomarker, and treatment data. The primary outcome was in-hospital death.

From a total of 1150 hospital admitted adults with laboratory-confirmed COVID-19, 22% met criterial for being "critically ill".  Such patients were older (mean 62 years), mostly men (67%)  and 82% had at least one comorbidity (HTN 63%, DM 36%, obesity 46%).

By April 28, 2020, 39% patients had died and 37% remained hospitalised.  Nearly 80% required mechanical ventilation (median 18 days), two-thirds received vasopressors and 31% required renal replacement therapy.

On average these patients quickly deteriorated (median 3 days).

In hospital mortality was associated with older age (adjusted hazard ratio 1·31 [1·09–1·57]), chronic cardiac disease (aHR 1·76), chronic pulmonary disease (aHR 2·94), higher interleukin-6 levels (aHR 1·11) and high D-dimers (aHR 1·10).

Older men, with comorbidities, who were infected with COVID-19 were most likely to be critically-ill in this cohort.

ADD THE FIRST COMMENT

If you are a health practitioner, you may to comment.

Due to the nature of these comment forums, only health practitioners are allowed to comment at this time.

Disclosures
The author has no conflicts of interest to disclose related to this subject